Recent Alerts

Don't miss this Biotech stock

PDF Print E-mail

Hot Stock Picks for Wednesday 07-27-2011

MYRX - Myriad Pharmaceuticals, a biotechnology company is developing small molecule drugs for the treatment of cancer. The company?s product pipeline includes clinical and pre-clinical product candidates with mechanisms of action and novel chemical structures.

Its product candidates in clinical development include Azixa (MPC-6827), which is under Phase II clinical trial for the treatment of metastatic melanoma. In addition the company has a strong pipe line of drugs under development. Very Attractive, must be on your list.

Get Alerts that MakeMoneyEverything else:HOTair© 

 
OTCKing
Sound View Plaza, 7th Floor
1266 E Main St.
Stamford, CT 06902, US
FREE! Premium Membership. DON'T miss the next Exclusive Alert! Become
a MEMBER Today!

Look for exclusive alerts

The Score Card

ARTI.PK* 0.0021   + 52%
EHSK.PK 0.17   + 108%
HGSI 3.35   + 226%
INCC.OB 0.01   + 346%
JGPK.OB 0.18   + 116%
STZU.PK 0.12   + 41%
TTEG.OB 0.36   + 156%
Look us up ON
these and other
PREMIER FINANCIALweb sites.
Bloomberg
FREE! Premium Membership. DON'T miss the next Exclusive Alert! Become a MEMBER Today!